PTHS Stock Analysis: Buy, Sell, or Hold?

PTHS - Pelthos Therapeutics Inc.

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$24.02
-1.76 (-6.83%) ▼
5d: -2.95%
30d: -12.62%
90d: -26.09%
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 26, 2026

Get Alerted When PTHS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: PTHS shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.

In-depth Analysis How we analyze

Valuation Analysis: PTHS is currently trading at $24.02, which is considered slightly low relative to its 30-day fair value range of $23.94 to $27.85.

Technical Outlook: Technically, PTHS is in a downtrend. Immediate support is located at $22.35, while resistance sits at $27.00. Short-term momentum is weak, with the stock down 6.8% recently.

Market Sentiment: PTHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $23.94 - $27.85
Company Quality Score 52/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 88.2%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-6.8%)

Fair Price Analysis

30-Day Fair Range $23.94 - $27.85
Current vs Fair Value SLIGHTLY LOW

Support & Resistance Levels

Support Level $22.35
Resistance Level $27.00
Current Trend Downtrend

Fundamental Context

Last updated: February 01, 2026 9:37 PM ET
Data refreshes hourly during market hours. Next update: 10:37 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$514 62 BUY
IONS
Ionis Pharmaceuticals Inc
BUY
26 analysts
$91 64 BUY
INSM
Insmed Inc
STRONG BUY
19 analysts
$215 60 BUY
REGN
Regeneron Pharmaceutical…
STRONG BUY
25 analysts
$847 52 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$89 61 BUY

More Analysis for PTHS

PTHS Technical Chart PTHS Price Prediction PTHS Earnings Date PTHS Investment Advisor PTHS Fair Price Analyzer PTHS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals